Effects of High Dose Inhaled Budesonide+ Formoterol Versus Placebo and Oral Prednisolone on Biomarkers of Airway Inflammation in the Treatment of Exacerbations in Non-hospitalised Patients With Mild to Moderate COPD.
Phase of Trial: Phase III
Latest Information Update: 21 Jan 2011
At a glance
- Drugs Budesonide/formoterol; Prednisolone
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- 21 Jan 2011 Trial phase changed from III to II as reported by ClinicalTrials.gov.
- 21 Nov 2005 New trial record.